| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |